{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:39:31Z","timestamp":1766086771094},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1997,8]]},"DOI":"10.1212\/wnl.49.2.421","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:29:48Z","timestamp":1336915788000},"page":"421-426","source":"Crossref","is-referenced-by-count":34,"title":["Potential therapeutic use of the selective dopamine D\n            <sub>1<\/sub>\n            receptor agonist, A-86929: An acute study in parkinsonian levodopa-primed monkeys"],"prefix":"10.1212","volume":"49","author":[{"given":"Richard","family":"Grondin","sequence":"first","affiliation":[{"name":"From the Department of Pharmacology (Mr. Grondin and Dr. Be\u0301dard), Faculty of Medecine, Laval University and Centre de Recherche en Neurobiologie, Ho\u0302pital de l'Enfant-Jesus, Que\u0301bec, Canada; and Neuroscience Research (Drs. Britton and Shiosaki), Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Be\u0301dard","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology (Mr. Grondin and Dr. Be\u0301dard), Faculty of Medecine, Laval University and Centre de Recherche en Neurobiologie, Ho\u0302pital de l'Enfant-Jesus, Que\u0301bec, Canada; and Neuroscience Research (Drs. Britton and Shiosaki), Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald R.","family":"Britton","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology (Mr. Grondin and Dr. Be\u0301dard), Faculty of Medecine, Laval University and Centre de Recherche en Neurobiologie, Ho\u0302pital de l'Enfant-Jesus, Que\u0301bec, Canada; and Neuroscience Research (Drs. Britton and Shiosaki), Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Shiosaki","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology (Mr. Grondin and Dr. Be\u0301dard), Faculty of Medecine, Laval University and Centre de Recherche en Neurobiologie, Ho\u0302pital de l'Enfant-Jesus, Que\u0301bec, Canada; and Neuroscience Research (Drs. Britton and Shiosaki), Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/277009a0"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(92)90003-O"},{"key":"e_1_3_1_4_2","first-page":"2","volume":"8","year":"1993","unstructured":"Strange PG. Dopamine receptors in the basal ganglia: relevance to Parkinson's disease. Mov Disord 1993;8:263-270.","journal-title":"Mov Disord"},{"key":"e_1_3_1_5_2","first-page":"3","volume":"40","year":"1990","unstructured":"Nutt JG. Levodopa-induced dyskinesia: review, observations, and speculations. Neurology 1990;40:340-345.","journal-title":"Neurology"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.44.1.1"},{"key":"e_1_3_1_7_2","first-page":"2","volume":"379","year":"1986","unstructured":"B\u00e9dard PJ, Di Paolo T, Falardeau P, Boucher R. Chronic treatment with L-dopa, but not bromocriptine, induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H] spiperone binding. Brain Res 1986;379:294-299.","journal-title":"Brain Res"},{"key":"e_1_3_1_8_2","first-page":"4","volume":"68","year":"1987","unstructured":"Braun A, Fabbrini G, Mouradian MM, Serrati C, Barone P, Chase TN. Selective D1 dopamine receptor agonist treatment of Parkinson's disease. J Neural Transm 1987;68:41-50.","journal-title":"J Neural Transm"},{"key":"e_1_3_1_9_2","first-page":"3","volume":"57","year":"1985","unstructured":"Nomoto M, Jenner P, Marsden CD. The dopamine D2 agonist LY-141865, but not the D1 agonist SKF-38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset. Neurosci Lett 1985;57:37-41.","journal-title":"Neurosci Lett"},{"key":"e_1_3_1_10_2","first-page":"5","volume":"150","year":"1988","unstructured":"Falardeau P, Bouchard S, B\u00e9dard PJ, Boucher R, Di Paolo T. Behavioral and biochemical effect of chronic treatment with D1 and\/or D2 dopamine agonists in MPTP monkeys. Eur J Pharmacol 1988;150:59-66.","journal-title":"Eur J Pharmacol"},{"key":"e_1_3_1_11_2","first-page":"2","volume":"104","year":"1989","unstructured":"B\u00e9dard PJ, Boucher R. Effect of D1 receptor stimulation in normal and MPTP monkeys. Neurosci Lett 1989;104:223-228.","journal-title":"Neurosci Lett"},{"key":"e_1_3_1_12_2","first-page":"9","volume":"40","year":"1990","unstructured":"Boyce S, Rupniak NMJ, Steventon MJ, Iversen SD. Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease. Neurology 1990;40:927-933.","journal-title":"Neurology"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(92)90105-Y"},{"key":"e_1_3_1_14_2","first-page":"5","volume":"31","year":"1992","unstructured":"Luquin MR, Laguna J, Obeso JA. Selective D2 receptor stimulation induces dyskinesia in parkinsonian monkeys. Ann Neurol 1992;31:551-554.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_15_2","first-page":"3","volume":"199","year":"1991","unstructured":"Taylor JR, Lawrence MS, Redmond DE Jr, et al. Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys. Eur J Pharmacol 1991;199:389-391.","journal-title":"Eur J Pharmacol"},{"key":"e_1_3_1_16_2","first-page":"2","volume":"229","year":"1992","unstructured":"Kebabian JW, Britton DR, DeNinno MP, et al. A-77636: a potent and selective dopamine D1 receptor agonist with anti-parkinsonian activity in marmosets. Eur J Pharmacol 1992;229:203-209.","journal-title":"Eur J Pharmacol"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90812-V"},{"key":"e_1_3_1_18_2","first-page":"2","volume":"267","year":"1993","unstructured":"Blanchet PJ, B\u00e9dard PJ, Britton DR, Kebabian JW. Differential effect of selective D1 and D2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys. J Pharmacol Exp Ther 1993;267:275-279.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00315-9"},{"key":"e_1_3_1_20_2","first-page":"8","volume":"24","year":"1988","unstructured":"Sage JI, Trooskin S, Sonsalla PK, Heikkila R, Duvoisin RC. Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonism. Ann Neurol 1988;24:87-89.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_21_2","first-page":"9","volume":"40","year":"1990","unstructured":"Cedarbaum JM, Silvestri M, Kutt H. Sustained enteral administration of levodopa increases and interrupted infusion decreases levodopa dose requirements. Neurology 1990;40:995-997.","journal-title":"Neurology"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270102"},{"key":"e_1_3_1_23_2","first-page":"1","volume":"43","year":"1993","unstructured":"Kurth MC, Tetrud JW, Tanner CM, et al. Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa\/carbidopa in Parkinson's disease patients with \"on-off\" fluctuations. Neurology 1993;43:1698-1703.","journal-title":"Neurology"},{"key":"e_1_3_1_24_2","first-page":"3","volume":"38","year":"1995","unstructured":"Michealides MR, Hong Y, DiDomenico S, et al.(5aR,11bs)-4,5,5a,6,7,11b-Hexahydro-2-propyl-3-thia-5-azacyclopent-1-ena[c]phenanthrene-9,10-diol(A-86929): a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration, and characterization of its diacetyl prodrug (ABT-431). J Med Chem 1995;38:3445-3447.","journal-title":"J Med Chem"},{"key":"e_1_3_1_25_2","first-page":"1","volume":"276","year":"1995","unstructured":"Shiosaki K, Jenner P, Asin KE, et al. ABT-431: the diacetyl prodrug of A-86929, a potent selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease. J Pharmacol Exp Ther 1995;276:150-160.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_26_2","first-page":"3","volume":"15","year":"1992","unstructured":"Rupniak NMJ, Boyce S, Steventon MJ, Iversen SD. Weak antiparkinsonian activity of the D1 agonist C-APB (SKF-82958) and lack of synergism with a D2 agonist in primates. Clin Neuropharmacol 1992;15:307-309.","journal-title":"Clin Neuropharmacol"},{"key":"e_1_3_1_27_2","first-page":"5","volume":"25","year":"1989","unstructured":"Mouradian MM, Heuser IJE, Baronti F, Fabbrini G, Juncos JL, Chase TN. Pathogenesis of dyskinesias in Parkinson's disease. Ann Neurol 1989;25:523-526.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_28_2","first-page":"1","volume":"43","year":"1993","unstructured":"Schuh LA, Bennett JP Jr. Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease. Neurology 1993;43:1545-1550.","journal-title":"Neurology"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870090103"},{"key":"e_1_3_1_30_2","first-page":"2","volume":"16","year":"1993","unstructured":"Surmeier JD, Reiner A, Levine MS, Ariano MA. Are neostriatal dopamine receptors co-localized? Trends Neurosci 1993;16:299-305.","journal-title":"Are neostriatal dopamine receptors co-localized? Trends Neurosci"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.250.4980.1"},{"key":"e_1_3_1_32_2","first-page":"3","volume":"528","year":"1990","unstructured":"Harrison MB, Wiley RG, Wooten FG. Selective localization of striatal D1 receptors to striatonigral neurons. Brain Res 1990;528:317-322.","journal-title":"Brain Res"},{"key":"e_1_3_1_33_2","first-page":"3","volume":"590","year":"1992","unstructured":"Harrison MB, Wiley RG, Wooten FG. Changes in D2 but not D1 receptor binding in the striatum following a selective lesion of striatopallidal neurons. Brain Res 1992;590:305-310.","journal-title":"Brain Res"},{"key":"e_1_3_1_34_2","first-page":"4","volume":"88","year":"1991","unstructured":"Le Moine C, Norman E, Bloch B. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc Natl Acad Sci USA 1991;88:4205-4209.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_35_2","first-page":"7","volume":"65","year":"1995","unstructured":"Yung KKL, Bolam JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 1995;65:709-730.","journal-title":"Neuroscience"},{"key":"e_1_3_1_36_2","first-page":"5","volume":"171","year":"1979","unstructured":"Hammond C, Feger J, Bioulac B, Souteyrand JP. Experimental hemiballism in the monkey produced by unilateral kainic acid lesion in corpus Luysii. Brain Res 1979;171:577-580.","journal-title":"Brain Res"},{"key":"e_1_3_1_37_2","first-page":"1","volume":"68","year":"1992","unstructured":"Hamada I, DeLong MR. Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs. J Neurophysiol 1992;68:1850-1858.","journal-title":"J Neurophysiol"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/111.1.1"},{"key":"e_1_3_1_39_2","first-page":"4","volume":"46","year":"1984","unstructured":"Jackson A, Crossman AR. Experimental choreoathetosis produced by injection of gamma-aminobutyric acid into the lentiform nucleus in the monkey. Neurosci Lett 1984;46:41-45.","journal-title":"Neurosci Lett"},{"key":"e_1_3_1_40_2","first-page":"4","volume":"108","year":"1985","unstructured":"Mitchell IJ, Sambrook MA, Crossman AR. Subcortical changes in the regional uptake of [3H]-2-deoxyglucose in the brain of the monkey during experimental choreiform dyskinesia elicited by injection of gamma-aminobutyric acid antagonist into the subthalamic nucleus. Brain 1985;108:405-422.","journal-title":"Brain"},{"key":"e_1_3_1_41_2","first-page":"1","volume":"5","year":"1990","unstructured":"Crossman AR. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment. Mov Disord 1990;5:100-108.","journal-title":"Mov Disord"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(93)90038-N"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)90567-F"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00464-G"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)94787-X"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(94)90022-1"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.49.2.421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:27:54Z","timestamp":1711549674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.49.2.421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["10.1212\/WNL.49.2.421"],"URL":"https:\/\/doi.org\/10.1212\/wnl.49.2.421","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}